{
  "extraction_version": "1.0",
  "extraction_date": "2026-02-23",
  "patient": {
    "id": "CCC-782934",
    "age": 66,
    "gender": "Female"
  },
  "cancer": {
    "type": "Lung adenocarcinoma",
    "subtype": "Non-GCB (ABC type)",
    "stage": "IVA",
    "primary_site": "Right upper lobe",
    "metastases": [
      "Mediastinal nodes",
      "Malignant pleural effusion"
    ],
    "biomarkers": {
      "pdl1_expression": "65% TPS",
      "tmb": "18 mutations/megabase",
      "msi_status": "MSS"
    },
    "diagnosis_date": "2025-12-08"
  },
  "immunotherapy": {
    "therapy_type": "ICI",
    "drug_name": "Pembrolizumab",
    "drug_class": "PD-1 inhibitor",
    "treatment_setting": "First-line",
    "line_of_therapy": "First-line",
    "planned_start_date": "2026-02-19",
    "ici_details": {
      "ici_target": "PD-1",
      "PD-L1": "65% TPS",
      "CTLA-4": null
    },
    "act_details": null
  },
  "prior_treatments": {
    "chemotherapy": {
      "received": false,
      "regimens": [],
      "response": ""
    },
    "prior_immunotherapy": {
      "received": false,
      "drugs": [],
      "response": ""
    }
  },
  "medications": {
    "ppi_use": {
      "currently_on_ppi": false,
      "ppi_name": "",
      "duration_months": 0
    },
    "antibiotic_history": {
      "recent_antibiotics": true,
      "exposures": [
        {
          "antibiotic_name": "Levofloxacin 750mg",
          "antibiotic_class": "fluoroquinolone",
          "start_date": "2025-12-28",
          "end_date": "2025-12-31",
          "days_before_ici": 49
        }
      ]
    }
  },
  "comorbidities": [],
  "microbiome": {
    "sample_date": "2026-02-07",
    "sequencing_method": "Shotgun metagenomic sequencing (Illumina NovaSeq, 15M reads)",
    "diversity": {
      "shannon_index": 3.6,
      "simpson_index": 0.91,
      "observed_species": 247
    },
    "key_bacteria": {
      "Akkermansia muciniphila": 4.8,
      "Faecalibacterium prausnitzii": 8.9,
      "Ruminococcaceae family": 14.2,
      "Bifidobacterium longum": 3.2,
      "Bifidobacterium adolescentis": 1.8,
      "Lachnospiraceae family": 12.8,
      "Roseburia intestinalis": 3.8,
      "Alistipes putredinis": 2.6,
      "Prevotella copri": 4.2,
      "Bacteroides spp.": 11.3,
      "E. coli": 1.2,
      "Enterococcus": 0.4,
      "Fusobacterium": 0.1
    },
    "metabolites": {
      "scfa": {
        "butyrate_uM": 32.8,
        "propionate_uM": 18.6,
        "acetate_uM": 58.4
      },
      "bile_acids_available": true,
      "tryptophan_metabolites_available": true
    },
    "data_quality": {
      "completeness": "high",
      "source": "Precision Microbiome Diagnostics",
      "limitations": []
    }
  },
  "clinical_context": {
    "urgency": "",
    "patient_goals": [],
    "specific_concerns": []
  }
}